Atralin

Product NDC: 13548-070
11-digit product format: 135480070
Labeler code: 13548
Product ID: 13548-070_77e095d6-f941-44ef-ad04-08d607843d65
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Tretinoin
Dosage form: GEL
Route: TOPICAL
Labeler: Bausch Health US, LLC
Application: NDA022070
Marketing category: NDA
Marketing start: 2007-07-26
Substance: TRETINOIN
Active strength: .05 g/100g
Pharmacologic classes: Retinoid [EPC], Retinoids [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	13548-070	13548-070-01	D	Discontinued by firm		2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022070-001	ATRALIN	TRETINOIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N022070-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N022070-001	ATRALIN	0.05%	GEL / TOPICAL	AB	RLD, RS	2007-07-26	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N022070-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022070-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022070-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022070-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022070-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022070-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022070-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022070-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022070-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022070-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022070-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022070-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022070-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022070-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022070-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022070-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022070-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022070-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022070-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022070-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022070-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022070-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022070-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022070-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022070-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022070-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022070-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022070-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022070-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022070-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022070-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022070-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022070-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022070-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022070-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022070-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022070-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022070-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N022070-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N022070-001	AB	1	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Atralin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
TRETINOIN	.05 g/100g

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
5688UTC01R	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
245723	Internal RxNorm lookup
749329	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
b6b45969-a64a-4ce3-b3b6-157d2568a301	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
b80ad7bc-1b6f-7ef4-1ed0-86cd9f459d60	Product name	6	20251124
1426d8f8-b7d5-4053-8554-613df00c0d86	Product name	2	20250616
0e7b8bf1-c46c-4de6-b26a-0c50e34364ec	Product name	2	20250521
e3af9708-3004-7392-4046-5311eaa8bab5	Product name	3	20221128
13e7e7e3-e885-4c79-af6d-dad1aedbb06e	Product name	1	20220128
503b047e-e62d-4745-9011-522b13bc701b	Product name	1	20181206
7d41caa2-0b5d-9b03-ab8d-84271de26ef4	Product name	2	20170314
50ca9ff5-82dd-9971-4f2c-5845a76a8572	Product name	2	20150818
0a8118e4-08c6-b395-9ddc-d3e425e0493a	Product name	1	20140508
233bcb0a-cf40-b0a1-b346-c83ac2f43579	Product name	1	20140508
85490a6b-2306-6bf2-c51b-eb63537dc2da	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
13548-070-01	Atralin	2 g in 1 TUBE	GEL	2	10
13548-070-45	Atralin	1 in 1 PACKAGE	GEL	1	10
13548-070-45	Atralin	45 g in 1 TUBE	GEL	45	10

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
13548-070-45	GM - Gram	13548-070	872ee8a3-2ea2-4151-af0e-525a05799883	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Tretinoin	ACTIVE INGREDIENT	5688UTC01R	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5
Tretinoin	ACTIVE MOIETY	5688UTC01R	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5
benzyl alcohol	INACTIVE INGREDIENT	LKG8494WBH	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5
butylated hydroxytoluene	INACTIVE INGREDIENT	1P9D0Z171K	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5
butylparaben	INACTIVE INGREDIENT	3QPI1U3FV8	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	INACTIVE INGREDIENT	4Q93RCW27E	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5
ethylparaben	INACTIVE INGREDIENT	14255EXE39	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5
glycerin	INACTIVE INGREDIENT	PDC6A3C0OX	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5
hyaluronate sodium	INACTIVE INGREDIENT	YSE9PPT4TH	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5
isobutylparaben	INACTIVE INGREDIENT	0QQJ25X58G	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5
methylparaben	INACTIVE INGREDIENT	A2I8C7HI9T	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5
octoxynol-9	INACTIVE INGREDIENT	7JPC6Y25QS	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5
phenoxyethanol	INACTIVE INGREDIENT	HIE492ZZ3T	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5
propylparaben	INACTIVE INGREDIENT	Z8IX2SC1OH	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5
trolamine	INACTIVE INGREDIENT	9O3K93S3TK	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5
water	INACTIVE INGREDIENT	059QF0KO0R	ATRALIN (TRETINOIN) GEL [CORIA LABORATORIES]	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
13548-070	ATRALIN (TRETINOIN) GEL [BAUSCH HEALTH US, LLC]	9	Current NDC, Legacy NDC, 3 package rows	20240423_b6b45969-a64a-4ce3-b3b6-157d2568a301.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tretinoin	TRETINOIN	Oceanside Pharmaceuticals	febda58b-c9ee-4b95-bee7-dca5f2645f98	2024-02-01	Warnings, Adverse reactions	Exact identifier application applno (NDA): 022070 application number: NDA022070
Atralin	TRETINOIN	Bausch Health US, LLC	b6b45969-a64a-4ce3-b3b6-157d2568a301	2024-02-01	Warnings, Adverse reactions	Exact identifier application applno (NDA): 022070 application number: NDA022070 ndc (product): 13548-070
Tretinoin	TRETINOIN	Obagi Cosmeceuticals LLC	c5ee36ac-2ffd-4cca-ad47-b1dae7ebdb3b	2021-05-01	Warnings, Adverse reactions	Exact identifier application applno (NDA): 022070 application number: NDA022070

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
5688UTC01R	TRETINOIN	302-79-4	TRETINOIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
749329	Atralin 0.05 % Topical Gel	PSN	b6b45969-a64a-4ce3-b3b6-157d2568a301	10
245723	tretinoin 0.05 % Topical Gel	PSN	b6b45969-a64a-4ce3-b3b6-157d2568a301	10
749329	tretinoin 0.0005 MG/MG Topical Gel [Atralin]	SBD	b6b45969-a64a-4ce3-b3b6-157d2568a301	10
245723	tretinoin 0.0005 MG/MG Topical Gel	SCD	b6b45969-a64a-4ce3-b3b6-157d2568a301	10
749329	Atralin 0.0005 MG/MG Topical Gel	SY	b6b45969-a64a-4ce3-b3b6-157d2568a301	10
749329	Atralin 0.05 % Topical Gel	SY	b6b45969-a64a-4ce3-b3b6-157d2568a301	10
245723	tretinoin 0.05 % Topical Gel	SY	b6b45969-a64a-4ce3-b3b6-157d2568a301	10

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
13548-070-01	13548007001	2 g in 1 TUBE	2 g					Historical
13548-070-45	13548007045	1 TUBE in 1 PACKAGE (13548-070-45) / 45 g in 1 TUBE	1 tube	2007-07-26	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Atralin	Bausch Health US, LLC \| Bausch Health Companies Inc.	2024-02-01	HUMAN PRESCRIPTION DRUG LABEL	10